More than 60 million Americans battle insomnia, and counting sheep, reading dull books or skipping naps isn't helping. Here ...
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
T he weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by ...
The Food and Drug Administration has approved Zepbound to treat obstructive sleep apnea for people who are moderately or ...
Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...
The NoLibs-based biz produces candles, perfumes, and incense, but their reed diffusers are perfect for overnight snoozin’, ...
The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.
The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...
Misdiagnosis happens in youngsters as it’s easy to dismiss symptoms as mood swings or work-induced stress, says psychiatrist ...